Senior insider sale
President & CEO at LYRA THERAPEUTICS, INC. — senior position signals high conviction
$9.0K
3.60K shares
What this filing means
PALASIS MARIA plans to sell 3.60K shares of LYRA THERAPEUTICS, INC. valued at approximately $9.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/27/2026ACC: 0001959173-26-000457
DirectorOfficer· President & CEO
Since Apr 2020
3.60K
Shares to sell
$9.0K
Approx. market value
1.90K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/12/2026
1.90KTotal acquired1.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/12/2026 | Restricted Stock Vesting Compensation | 1.90K | — |
| Total | 1.90K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.70K
Market value
$5.7K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.90K
Market value
$3.2K
1/27/2026
Total
Units
3.60K
Value
$9.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 1.70K | $5.7K | — | Completed |
| Planned — Approximate Date | ||||
1/27/2026 | 1.90K | $3.2K | NASDAQ | Planned |
| Total | 3.60K | $9.0K | ||